XML 73 R58.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Revenue Recognition (Details)
$ in Thousands
2 Months Ended 3 Months Ended 10 Months Ended 12 Months Ended
Mar. 02, 2019
USD ($)
Mar. 02, 2019
USD ($)
Dec. 01, 2018
USD ($)
Sep. 01, 2018
USD ($)
Jun. 02, 2018
USD ($)
Mar. 03, 2018
USD ($)
Dec. 02, 2017
USD ($)
Sep. 02, 2017
USD ($)
Jun. 03, 2017
USD ($)
Dec. 31, 2017
Mar. 02, 2019
USD ($)
Point
Mar. 03, 2018
USD ($)
Mar. 04, 2017
USD ($)
Mar. 04, 2018
USD ($)
Feb. 27, 2016
USD ($)
Intangible Assets                              
Estimated Useful Life                     10 years        
Estimated useful life of purchased prescription files acquired in other than business combinations                     5 years        
Deferred Financing Costs                              
Amortization expenses of deferred financing costs                     $ 10,761 $ 8,403 $ 4,696    
Revenue Recognition                              
Revenues   $ 5,379,645 $ 5,450,060 $ 5,421,362 $ 5,388,490 $ 5,394,264 $ 5,353,170 $ 5,345,011 $ 5,436,523   21,639,557 21,528,968 22,927,540    
Accounts receivable, net $ 1,788,712 1,788,712       1,869,100         1,788,712 1,869,100   $ 1,811,203  
Inventories, net 1,871,941 1,871,941       1,799,539         1,871,941 1,799,539   1,850,660  
Deferred tax assets 409,084 409,084       594,019         409,084 594,019   592,235  
Total assets 7,591,367 7,591,367       8,989,327         7,591,367 8,989,327   8,980,767  
Accumulated deficit (4,713,244) (4,713,244)       (4,282,471)         (4,713,244) (4,282,471)   (4,291,031)  
Total stockholders' equity $ 1,186,690 1,186,690       1,601,010         1,186,690 1,601,010 614,070 1,592,450 $ 581,428
Advertising                              
Advertising expenses, net of vendor advertising allowances                     $ 147,519 $ 161,826 $ 181,438    
Income Taxes                              
Federal statutory rate (as a percent) 21.00%                 35.00% 21.00% 32.60% 35.00%    
Difference between Revenue Guidance in Effect before and after Topic 606                              
Revenue Recognition                              
Accounts receivable, net                           (57,897)  
Inventories, net                           51,121  
Deferred tax assets                           (1,784)  
Total assets                           (8,560)  
Accumulated deficit                           (8,560)  
Total stockholders' equity                           (8,560)  
Intersegment elimination                              
Revenue Recognition                              
Revenues                     $ (211,283) $ (200,326) $ (232,964)    
Accounts receivable, net $ 14,459 14,459       16,256         14,459 16,256      
Total assets (14,459) (14,459)       (54,969)         $ (14,459) $ (54,969)      
Trade names                              
Intangible Assets                              
Finite-lived intangible assets amortization period                     10 years        
Customer relationships                              
Intangible Assets                              
Finite-lived intangible assets amortization period                     13 years 15 years      
CMS license                              
Intangible Assets                              
Finite-lived intangible assets amortization period                     22 years 23 years      
CMS license | EnvisionRx                              
Intangible Assets                              
Finite-lived intangible assets amortization period                     25 years        
Minimum                              
Insurance                              
Workers compensation occurrences 1,000 1,000                 $ 1,000        
General liability occurrences 3,000 3,000                 $ 3,000        
Minimum | Customer relationships | EnvisionRx                              
Intangible Assets                              
Finite-lived intangible assets amortization period                     10 years        
Maximum | Customer relationships | EnvisionRx                              
Intangible Assets                              
Finite-lived intangible assets amortization period                     20 years        
Buildings | Minimum                              
Property, Plant and Equipment                              
Useful life                     30 years        
Buildings | Maximum                              
Property, Plant and Equipment                              
Useful life                     45 years        
Equipment | Minimum                              
Property, Plant and Equipment                              
Useful life                     3 years        
Equipment | Maximum                              
Property, Plant and Equipment                              
Useful life                     15 years        
Internal-use software                              
Property, Plant and Equipment                              
Capitalized costs                     $ 13,716 $ 13,940 6,189    
Retail Pharmacy                              
Revenue Recognition                              
Number of points awarded for each dollar spent towards front end merchandise | Point                     1        
Number of points awarded for each qualifying prescription | Point                     25        
Accumulated number of points in a calendar year to achieve the "Gold" tier | Point                     1,000        
Percentage discount on qualifying purchases of front end merchandise on achieving "Gold" tier                     20.00%        
Accrued contract liabilities 63,720 63,720       63,851         $ 63,720 63,851      
Accrued contract liabilities included in other current liabilities 51,042 51,042       50,036         51,042 50,036      
Accrued contract liabilities included in noncurrent liabilities $ 12,678 $ 12,678       $ 13,815         $ 12,678 13,815      
Expiration window to redeem accumulated Bonus Cash (in days)                     60 days        
Revenues                     $ 15,757,152 15,832,625 16,766,620    
Retail Pharmacy | Other                              
Revenue Recognition                              
Revenues                     150,461 155,636 155,788    
Pharmacy sales                              
Revenue Recognition                              
Revenues                     10,391,539 10,328,376 11,072,480    
Front end sales                              
Revenue Recognition                              
Revenues                     5,215,152 5,348,613 5,538,352    
Pharmacy Services                              
Revenue Recognition                              
Revenues                     $ 6,093,688 $ 5,896,669 $ 6,393,884    
Vendor Rebates and Allowances and Purchase Discounts                              
Period for rebates are dispensed to manufacturers                     30 days        
Accounting Standards Update 2016-09                              
Revenue Recognition                              
Accounts receivable, net                           (57,897)  
Inventories, net                           51,121  
Accumulated deficit                           $ (8,560)